Biogen Message Board - Msg: 10095407

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 172.49

-2.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: P.M.Freedman who wrote (1027)	6/12/1999 6:50:00 PM
From: Harold Engstrom	Read Replies (1) of 1686

PMF, I sure wish you would stop saying Biogen doesn't have a pipeline. Also, you should know that Biogen has other MS treatments in the pipeline as well. I suggest you read the posts on this thread. There is excellent information here and on other SI threads. Antova is anti-CD40L. There is info about Antova here and on the Biotransplant (BTRN) thread and on the Idec thread. There have been several recent and relevant posts here - and links to analysts opinions - about developments regarding Amevive. "huge molecular weight" and "lower bioavailability"... I don't really know what to say to these statements... VLA4 has MS among its target indications. Asthma and RA are others.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next